Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan
Kazutaka Terahara(National Institute of Infectious Diseases), Yoshimasa Takahashi(Hokkaido Pharmaceutical University), Atsushi Naganuma(National Hospital Organization Takasaki Medical Center), Keiji Matsubayashi(Community Medical Center), Koichi Honda(Yamagata University), Hidekatsu Sakata(Japanese Red Cross Society, Japan), Tatsuya Kanto(National Center for Global Health and Medicine), Masanori Isogawa(Nagoya City University), Koji Ogawa(The Japanese Society of Gastroenterological Surgery), Jun Itakura(Musashino Red Cross Hospital), Hiroshi Tobita(Shimane University), Ryuichi Sugiyama(National Institute of Infectious Diseases), Tian‐Cheng Li(National Institute of Infectious Diseases), Ryosuke Suzuki(National Institute of Infectious Diseases), Masaaki Korenaga(National Center for Global Health and Medicine), Noriyuki Akutsu(Sapporo Medical University), Isao Hamaguchi(National Institute of Infectious Diseases), Takanobu Kato(National Institute of Infectious Diseases)
Cited by 4
Related Papers
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
|Biochemical and Biophysical Research Communications|2013|330
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241